Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
5
×
life sciences
boston top stories
clinical trials
national blog main
cancer
fda
national top stories
san francisco blog main
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
crispr therapeutics
detroit blog main
detroit top stories
drugs
eli lilly
european society for medical oncology
indiana blog main
indiana top stories
investing
loxo oncology
mirati therapeutics
national
new york blog main
new york top stories
nonalcoholic steatohepatitis
president trump
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
spinal muscular atrophy
startups
texas blog main
What
biotech
5
×
drug
5
×
annual
attention
bio
cancer
investment
ipo
lead
medicines
new
research
roundup
ahead
alzheimer’s
ambien
american
analysis
asco
assessed
attendees
black
bring
camp’s
cash
chicago
city
clinic
clinical
combinations
communities
community’s
companies
company
conference
days
develop
diamond
diseases
driving
Language
unset
Current search:
drug
×
biotech
×
" boston blog main "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More